Public companies and startups, clearly labelled, with pipeline stage, sources and the date each profile was verified. Profiles are informational, not investment advice.
Vertex develops small-molecule and genetic medicines for serious diseases and is best known for its cystic fibrosis drugs. It co-developed Casgevy, the…
CRISPR Therapeutics is a gene-editing company that co-developed Casgevy with Vertex. Its clinical pipeline includes in vivo editing programs for cardiovascular targets…
Moderna develops mRNA medicines and markets vaccines against COVID-19 and RSV. With Merck, it is developing intismeran autogene, an individualized neoantigen mRNA…
Intuitive makes the da Vinci robotic-assisted surgical systems used in minimally invasive procedures. Its fifth-generation platform, da Vinci 5, adds force-sensing instruments…
Illumina makes DNA sequencing instruments, reagents and software used widely in research and clinical genomics. It acquired GRAIL in 2021 and separated…
Recursion describes itself as a clinical-stage 'TechBio' company that combines automated biology and machine learning to find drug candidates. Its most advanced…
GRAIL develops blood tests for early cancer detection; its Galleri multi-cancer early detection test is sold in the U.S. as a laboratory-developed…
Hyperfine makes the Swoop system, a portable, ultra-low-field MRI scanner for brain imaging at the point of care. The company was founded…
insitro, founded by Daphne Koller, combines machine learning with human cellular data to identify disease drivers and design drug candidates. It has…
Altos Labs studies cellular rejuvenation — resetting aspects of cell state to restore health and resilience. It has research sites in the…
Retro Biosciences aims to extend healthy human lifespan through programs in autophagy, cell replacement and tissue reprogramming. Its lead oral drug, RTR242,…
NewLimit develops epigenetic reprogramming medicines intended to restore youthful function to aged cells, starting with liver cells. It was co-founded by Brian…
Company profiles and watchlists are informational. Scientific progress is not the same thing as investment performance, and a compelling technology never guarantees a rising stock.
Companies we follow closely, with the scientific milestones that matter. Science first; share prices are a separate question.
| Company | Status | Ticker | Most advanced stage | What to watch | Market data | Profile verified |
|---|---|---|---|---|---|---|
| CRISPR Therapeutics | Public | CRSP | Approved/marketed products | — | Not connected | 2026-09-25 |
| GRAIL | Public | GRAL | Approved/marketed products | — | Not connected | 2026-09-25 |
| Hyperfine | Public | HYPR | Approved/marketed products | — | Not connected | 2026-09-25 |
| Illumina | Public | ILMN | Approved/marketed products | — | Not connected | 2026-09-25 |
| Intuitive Surgical | Public | ISRG | Approved/marketed products | — | Not connected | 2026-09-25 |
| Moderna | Public | MRNA | Approved/marketed products | — | Not connected | 2026-09-25 |
| Recursion Pharmaceuticals | Public | RXRX | Phase 2 | — | Not connected | 2026-09-25 |
| Vertex Pharmaceuticals | Public | VRTX | Approved/marketed products | — | Not connected | 2026-09-25 |
Static example Live market data is not connected yet, so no prices are shown. When a reliable data source is connected, each price will display its source and timestamp. This watchlist is informational and is not a recommendation to buy or sell any security.